Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Siberiaon Jan 10, 2022 7:56pm
264 Views
Post# 34301965

💥THRM Should Anouce the Test for - “Deltacron”

💥THRM Should Anouce the Test for - “Deltacron”
A strain of Covid-19 that combines Delta and Omicron has been found in Cyprus, according to Leondios Kostrikis, professor of biological sciences at the University of Cyprus and head of the laboratory of biotechnology and molecular virology. There are currently Omicron and Delta co-infections and we found this strain that is a combination of these two, Kostrikis said in an interview on Friday. The discovery was named Deltacron due to the identification of Omicron-like genetic signatures within the Delta genomes, he said. Kostrikis and his team have identified 25 such cases and the statistical analysis shows that the relative frequency of the combined infection is higher among patients hospitalised due to Covid-19 as compared to non-hospitalised patients. More at: https://m.timesofindia.com/world/rest-of-world/cyprus-scientist-reports-strain-that-combines-delta-and-omicron/amp_articleshow/88799929.cms
<< Previous
Bullboard Posts
Next >>